Alpine Associates Management’s Inozyme Pharma INZY Stock Holding History

Alpine Associates Management’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,188,100	Closed	-$8.75M	–	85
2025 Q2	$8.75M	Buy	+2,188,100	New	+$5.42M	0.47%	43

Alpine Associates Management's INZY Position: Q3 2025 in Review

Alpine Associates Management sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 2,188,100 shares — an estimated $8.75M sold.

Alpine Associates Management first reported a position in INZY in Q2 2025 and held it in 1 quarter. The position peaked at $8.75M in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

Alpine Associates Management reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
Alpine Associates Management sold 2,188,100 Inozyme Pharma shares in Q3 2025, an estimated $8.75M.
Alpine Associates Management first reported a position in Inozyme Pharma in Q2 2025 and held it in 1 quarter.
Alpine Associates Management's Inozyme Pharma position peaked at $8.75M in Q2 2025.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Alpine Associates Management's 13F filing for Q3 2025, filed 6 Nov 2025.